Adding Mass Detection to Routine Peptide-Level Biotherapeutic Analyses with the ACQUITY QDa Detector

ADDING COST EFFECTIVE MASS DETECTION AS AN ORTHOGONAL TECHNIQUE FOR IMPROVED PRODUCTIVITY AND CONFIDENCE IN THE ANALYSIS OF PROTEIN BIOTHERAPEUTICS Robert E. Birdsall1, Sean M. McCarthy1, Jason Rouse2, Heather DeGruttola2 and Weibin Chen1. 1. Waters Corporation, Milford, MA. 2. Pfizer,…

P-111-T ADDING COST EFFECTIVE MASS DETECTION AS AN ORTHOGONAL TECHNIQUE FOR IMPROVED PRODUCTIVITY AND CONFIDENCE IN THE ANALYSIS OF PROTEIN BIOTHERAPEUTICS Robert E. Birdsall, Eoin Cosgrave, Sean M. McCarthy, Joe Fredette, Scott Berger and Weibin Chen Waters Corporation, Milford, MA…

Increasing Specificity and Sensitivity in Routine Peptide Analyses Using Mass Detection with the ACQUITY QDa Detector Robert E. Birdsall and Sean M. McCarthy Waters Corporation, Milford, MA, USA A P P L I C AT I O N B E…

MAIN MENU TABLE OF CONTENTS [ APPLICATIONS NOTEBOOK ] BIOSEPARATIONS Tools, Techniques, and Insights into Biopharmaceutical Analysis INT RODUCTION Biopharmaceuticals have emerged as a dominant class due to their specificity and efficacy. T he production of biopharmaceuticals, however, is distinctly…